Health&Beauty- Page 35

The FINANCIAL -- Ozempic (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death (collectively termed major adverse cardiovascular events, MACE) in people with type 2 diabetes at high

The FINANCIAl -- Boston, MA – Technological innovation, expansion of the use of frontline personnel such as community health workers, and rapid increases in health care financing are likely to be instrumental to achieving universal health care (UHC) in countries around the

The FINANCIAL --  Study, by University of Washington (UW) researchers, involved 3,877 adults age 65 and older, who were part of an ongoing, prospective cohort study initiated in 1994 ("Adult Changes in Thought"). From the outset, dementia-free, study participants were assessed for

The FINANCIAL -- 'Blue light accelerates blindness,' headlines declare following new research, but doctors warn that reports of digital screen-time-induced vision loss are greatly exaggerated.

The FINANCIAL -- NEW YORK and TOKYO, August 22, 2018 –Pfizer Inc. and Astellas Pharma Inc.  announced amendments to the protocols for two registrational Phase 3 trials, ARCHES and EMBARK, designed to evaluate the safety and efficacy of XTANDI in men with

The FINANCIAL -- THOUSAND OAKS, Calif. -- Amgen announced the upcoming presentation of new Repatha (evolocumab) analyses, including a late-breaking study evaluating the efficacy of Repatha in patients with metabolic syndrome and established cardiovascular disease at the ESC Congress 2018, organized by

The FINANCIAL -- William T. Reynolds, O.D., specializes in caring for patients calls "mature" at private group practice in Richmond, Kentucky. On average, the patients range in age from 45 to 75, though most are over 60.

The FINANCIAL -- WARSAW, Ind. – While many who suffer from knee or hip pain know that it impacts their everyday activities, results from a new survey show the significant emotional impact of joint pain. This includes impact on romantic and social

The FINANCIAL -- Shanghai, China, August 20, 2018 - CANbridge Life Sciences, a biotech company privately-held and headquartered in Beijing, China, announced that it has received Clinical Trial Application (CTA) approval from the China Food and Drug Administration (CFDA) to conduct clinical

The FINANCIAL -- The Bristol-Myers Squibb-Pfizer Alliance will present 15 Eliquis posters at the ESC Congress 2018 held in Munich, Germany, August 25-29, 2018. Nine of the posters to be presented are new analyses from the global real-world data (RWD) program, ACROPOLIS